Clinical Trial Update: PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing telmisartan/hydrochlorothiazide (40/12.5 or 80/12.5) with losartan/hydrochlorothiazide (50/12.5) for hypertension, using ambula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Losartan/Hydrochlorothiazide (losartan/hydrochlorothiazide)
• Telmisartan/Hydrochlorothiazide (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED